miRNA‑218 targets multiple oncogenes and is a therapeutic target for osteosarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miRNA‑218 targets multiple oncogenes and is a therapeutic target for osteosarcoma

Published:2022-03-15 Issue:5 Volume:47 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Sato Kentaro¹,Osaka Eiji²,Fujiwara Kyoko³,Fujii Ryota²,Takayama Tadateru³,Tokuhashi Yasuaki⁴,Nakanishi Kazuyoshi²

Affiliation:

1. Department of Orthopedic Surgery, Nihon University Hospital, Chiyoda‑ku, Tokyo 101‑8309, Japan

2. Department of Orthopedic Surgery, Nihon University School of Medicine, Itabashi‑ku, Tokyo 173‑8610, Japan

3. Department of Internal Medicine, Nihon University School of Medicine, Itabashi‑ku, Tokyo 173‑8610, Japan

4. Department of Orthopedic Surgery, Tachikawa Kinen Hospital, Kasama City, Ibaraki 309‑1736, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Reference46 articles.

1. Osteosarcoma;Eaton;Pediatr Blood Cancer,2021

2. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols;Bielack;J Clin Oncol,2002

3. Osteosarcoma relapse after combined modality therapy: An analysis of unselected patients in the cooperative osteosarcoma study group (COSS);Kempf-Bielack;J Clin Oncol,2005

4. Molecular targeted therapy: Treating cancer with specificity;Lee;Eur J Pharmacol,2018

5. Molecular pathology and its diagnostic use in bone tumors;Szuhai;Cancer Genet,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of survivin expression and regulating miRNAs of survivin expression in peripheral blood mononuclear cells in systemic lupus erythematous patients;Lupus;2024-08-20

2. The current perspective and opportunities of small nucleic acid‐based therapeutics;Drug Development Research;2024-02-27

3. Overview of role of survivin in cancer: expression, regulation, functions, and its potential as a therapeutic target;Journal of Drug Targeting;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3